Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Age-Related Pathology Associated with H1N1 A/California/07/2009 Influenza Virus Infection.

Bissel SJ, Carter CE, Wang G, Johnson SK, Lashua LP, Kelvin AA, Wiley CA, Ghedin E, Ross TM.

Am J Pathol. 2019 Dec;189(12):2389-2399. doi: 10.1016/j.ajpath.2019.08.017. Epub 2019 Oct 1.

PMID:
31585069
2.

Cachexia/Protein energy wasting syndrome in CKD: Causation and treatment.

Oliveira EA, Zheng R, Carter CE, Mak RH.

Semin Dial. 2019 Nov;32(6):493-499. doi: 10.1111/sdi.12832. Epub 2019 Jul 8.

PMID:
31286575
3.

Economic performance and cost-effectiveness of using a DEC-salt social enterprise for eliminating the major neglected tropical disease, lymphatic filariasis.

Sharma S, Smith ME, Reimer J, O'Brien DB, Brissau JM, Donahue MC, Carter CE, Michael E.

PLoS Negl Trop Dis. 2019 Jul 1;13(7):e0007094. doi: 10.1371/journal.pntd.0007094. eCollection 2019 Jul.

4.

The effect of frailty on HAI response to influenza vaccine among community-dwelling adults ≥ 50 years of age.

Moehling KK, Nowalk MP, Lin CJ, Bertolet M, Ross TM, Carter CE, Susick M, Saul SG, Kaynar AM, Bromberger JT, Zimmerman RK.

Hum Vaccin Immunother. 2018 Feb 1;14(2):361-367. doi: 10.1080/21645515.2017.1405883. Epub 2017 Dec 20.

5.

Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination.

Lee J, Boutz DR, Chromikova V, Joyce MG, Vollmers C, Leung K, Horton AP, DeKosky BJ, Lee CH, Lavinder JJ, Murrin EM, Chrysostomou C, Hoi KH, Tsybovsky Y, Thomas PV, Druz A, Zhang B, Zhang Y, Wang L, Kong WP, Park D, Popova LI, Dekker CL, Davis MM, Carter CE, Ross TM, Ellington AD, Wilson PC, Marcotte EM, Mascola JR, Ippolito GC, Krammer F, Quake SR, Kwong PD, Georgiou G.

Nat Med. 2016 Dec;22(12):1456-1464. doi: 10.1038/nm.4224. Epub 2016 Nov 7.

6.

Optimizing Music Learning: Exploring How Blocked and Interleaved Practice Schedules Affect Advanced Performance.

Carter CE, Grahn JA.

Front Psychol. 2016 Aug 18;7:1251. doi: 10.3389/fpsyg.2016.01251. eCollection 2016.

7.

Validated predictive modelling of the environmental resistome.

Amos GC, Gozzard E, Carter CE, Mead A, Bowes MJ, Hawkey PM, Zhang L, Singer AC, Gaze WH, Wellington EM.

ISME J. 2015 Jun;9(6):1467-76. doi: 10.1038/ismej.2014.237. Epub 2015 Feb 13.

8.

Urinary creatinine and survival in CKD.

Carter CE, Ix JH.

Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2028-9. doi: 10.2215/CJN.10121014. Epub 2014 Nov 7. No abstract available.

9.

Influence of urine creatinine concentrations on the relation of albumin-creatinine ratio with cardiovascular disease events: the Multi-Ethnic Study of Atherosclerosis (MESA).

Carter CE, Katz R, Kramer H, de Boer IH, Kestenbaum BR, Peralta CA, Siscovick D, Sarnak MJ, Levey AS, Inker LA, Allison MA, Criqui MH, Shlipak MG, Ix JH.

Am J Kidney Dis. 2013 Oct;62(4):722-9. doi: 10.1053/j.ajkd.2013.05.010. Epub 2013 Jul 2.

10.

Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013.

Carter CE, Benador NM.

Pediatr Nephrol. 2014 Jan;29(1):35-50. doi: 10.1007/s00467-013-2479-7. Epub 2013 Jun 29. Review.

PMID:
23812351
11.

Nephrotic syndrome in an 18-year-old boy with congenital myelomeningocele: questions.

Carter CE, Shayan K, Mak RH, Yorgin PD, Krous HF.

Pediatr Nephrol. 2013 Oct;28(10):1963-4, 1965-7. doi: 10.1007/s00467-012-2349-8. Epub 2012 Nov 8. No abstract available.

PMID:
23135608
12.

How many mountains can we mine? Assessing the regional degradation of Central Appalachian rivers by surface coal mining.

Bernhardt ES, Lutz BD, King RS, Fay JP, Carter CE, Helton AM, Campagna D, Amos J.

Environ Sci Technol. 2012 Aug 7;46(15):8115-22. doi: 10.1021/es301144q. Epub 2012 Jul 25.

PMID:
22788537
13.

Influence of urine creatinine on the relationship between the albumin-to-creatinine ratio and cardiovascular events.

Carter CE, Gansevoort RT, Scheven L, Heerspink HJ, Shlipak MG, de Jong PE, Ix JH.

Clin J Am Soc Nephrol. 2012 Apr;7(4):595-603. doi: 10.2215/CJN.09300911. Epub 2012 Mar 1.

14.

Gold mining in the Peruvian Amazon: global prices, deforestation, and mercury imports.

Swenson JJ, Carter CE, Domec JC, Delgado CI.

PLoS One. 2011 Apr 19;6(4):e18875. doi: 10.1371/journal.pone.0018875.

15.

Widespread contribution of methane-cycle bacteria to the diets of lake profundal chironomid larvae.

Jones RI, Carter CE, Kelly A, Ward S, Kelly DJ, Grey J.

Ecology. 2008 Mar;89(3):857-64.

PMID:
18459348
16.

The development of a measure to assess putative mechanisms of change in the treatment of borderline personality disorder.

Levy KN, Wasserman RH, Scott LN, Zach SE, White CN, Cain NM, Fischer C, Carter CE, Clarkin JF, Kernberg OF.

J Am Psychoanal Assoc. 2006 Fall;54(4):1325-31. No abstract available.

PMID:
17354506
17.

Functional studies on the anti-pathoangiogenic properties of CM101.

Yan HP, Carter CE, Wang EZ, Page DL, Washington K, Wamil BD, Yakes FM, Thurman GB, Hellerqvist CG.

Angiogenesis. 1998;2(3):219-33.

PMID:
14517462
18.

Detection of Trypanosoma cruzi DNA within murine cardiac tissue sections by in situ polymerase chain reaction.

Lane JE, Ribeiro-Rodrigues R, Olivares-Villagómez D, Vnencak-Jones CL, McCurley TL, Carter CE.

Mem Inst Oswaldo Cruz. 2003 Apr;98(3):373-6. Epub 2003 Jul 18.

19.

Evolution of functional diversity in the cupin superfamily.

Dunwell JM, Culham A, Carter CE, Sosa-Aguirre CR, Goodenough PW.

Trends Biochem Sci. 2001 Dec;26(12):740-6.

PMID:
11738598
20.

CM101 treatment overrides tumor-induced immunoprivilege leading to apoptosis.

Yakes FM, Wamil BD, Sun F, Yan HP, Carter CE, Hellerqvist CG.

Cancer Res. 2000 Oct 15;60(20):5740-6.

21.
22.

Isolation and identification of the group B streptococcal toxin CM101 from infants with sepsis.

Sundell HW, Yan H, Carter CE, Wamil BD, Wu K, Gaddipati R, Li D, Hellerqvist CG.

J Pediatr. 2000 Sep;137(3):338-44.

PMID:
10969257
23.

Phytochrome regulation of phytochrome A mRNA levels in the model short-day-plant Pharbitis nil.

Carter CE, Szmidt-Jaworska A, Hughes M, Thomas B, Jackson S.

J Exp Bot. 2000 Apr;51(345):703-11.

PMID:
10938862
24.
25.

Polymerase chain reaction amplification of three different Trypanosoma cruzi DNA sequences from human chagasic cardiac tissue.

Olivares-Villagómez D, McCurley TL, Vnencak-Jones CL, Correa-Oliveira R, Colley DG, Carter CE.

Am J Trop Med Hyg. 1998 Oct;59(4):563-70.

PMID:
9790431
26.

Ultrastructural effects of the chelating agent 1,10-phenanthroline on Trypanosoma cruzi epimastigotes in vitro.

Lane JE, Bogitsh BJ, Ribeiro-Rodrigues R, Kral MV, Jones MM, Carter CE.

Parasitol Res. 1998 May;84(5):399-402.

PMID:
9610638
27.

Cadmium-induced apoptosis in the urogenital organs of the male rat and its suppression by chelation.

Yan H, Carter CE, Xu C, Singh PK, Jones MM, Johnson JE, Dietrich MS.

J Toxicol Environ Health. 1997 Oct 10;52(2):149-68.

PMID:
9310147
28.

Detection of Trypanosoma cruzi with the polymerase chain reaction and in situ hybridization in infected murine cardiac tissue.

Lane JE, Olivares-Villagomez D, Vnencak-Jones CL, McCurley TL, Carter CE.

Am J Trop Med Hyg. 1997 Jun;56(6):588-95. Review.

PMID:
9230784
29.

Nitrate losses in runoff and subsurface drain effluent from controlled-water-table plots.

Willis GH, Southwick LM, Fouss JL, Carter CE, Rogers JS.

Bull Environ Contam Toxicol. 1997 Apr;58(4):566-73. No abstract available.

PMID:
9060374
30.

Phase I study of the antineovascularization drug CM101.

DeVore RF, Hellerqvist CG, Wakefield GB, Wamil BD, Thurman GB, Minton PA, Sundell HW, Yan HP, Carter CE, Wang YF, York GE, Zhang MH, Johnson DH.

Clin Cancer Res. 1997 Mar;3(3):365-72.

31.

Synthesis and in vitro trypanocidal activity of some novel iron chelating agents.

Singh PK, Jones MM, Lane JE, Nesset A, Zimmerman LJ, Ribeiro-Rodrigues R, Richter A, Stenger MR, Carter CE.

Arzneimittelforschung. 1997 Mar;47(3):311-5.

PMID:
9105552
32.

The in vitro effects of extracellular adenosine triphosphate on the ultrastructure of Trypanosoma cruzi epimastigotes.

Bogitsh BJ, Ribeiro-Rodrigues R, Carter CE.

Parasitol Res. 1997;83(6):624-6.

PMID:
9211517
33.

Inhibition of Trypanosoma cruzi epimastigotes in vitro by iron chelating agents.

Jones MM, Singh PK, Lane JE, Rodrigues RR, Nesset A, Suarez CC, Bogitsh BJ, Carter CE.

Arzneimittelforschung. 1996 Dec;46(12):1158-62.

PMID:
9006792
34.

In vitro trypanocidal activity of tetraethylthiuram disulfide and sodium diethylamine-N-carbodithioate on Trypanosoma cruzi.

Lane JE, Ribeiro-Rodrigues R, Suarez CC, Bogitsh BJ, Jones MM, Singh PK, Carter CE.

Am J Trop Med Hyg. 1996 Sep;55(3):263-6.

PMID:
8842112
35.
36.

In vivo studies of cadmium-induced apoptosis in testicular tissue of the rat and its modulation by a chelating agent.

Xu C, Johnson JE, Singh PK, Jones MM, Yan H, Carter CE.

Toxicology. 1996 Jan 22;107(1):1-8.

PMID:
8597027
37.
38.

Chelating agent inhibition of Trypanosoma cruzi epimastigotes in vitro.

Rodrigues RR, Lane JE, Carter CE, Bogitsh BJ, Singh PK, Zimmerman LJ, Molenda JJ, Jones MM.

J Inorg Biochem. 1995 Dec;60(4):277-88.

PMID:
8530923
39.
40.

Monoclonal antibodies for structure-function studies of (R)-3-hydroxybutyrate dehydrogenase, a lipid-dependent membrane-bound enzyme.

Adami P, Duncan TM, McIntyre JO, Carter CE, Fu C, Melin M, Latruffe N, Fleischer S.

Biochem J. 1993 Jun 15;292 ( Pt 3):863-72.

41.

An evaluation of the comparative tuberculin skin test for detecting tuberculosis in farmed deer.

Corrin KC, Carter CE, Kissling RC, de Lisle GW.

N Z Vet J. 1993 Mar;41(1):12-20.

PMID:
16031689
42.

Identification and characterization of an alpha-mannosidase from Trypanosoma cruzi.

Swanson PM, Carter CE, Hager C, Kim WJ, Obermeier S, Oeltmann TN.

Glycobiology. 1992 Dec;2(6):563-9.

PMID:
1472763
43.

PGE2 regulates cAMP production in cultured rabbit CCD cells: evidence for dual inhibitory mechanisms.

Noland TD, Carter CE, Jacobson HR, Breyer MD.

Am J Physiol. 1992 Dec;263(6 Pt 1):C1208-15.

PMID:
1335688
44.

Schistosoma japonicum: excretory-secretory products of the eggs during miracidial development.

Kawanaka M, Carter CE.

Exp Parasitol. 1992 Mar;74(2):143-50.

PMID:
1740176
45.
46.

The effect of praziquantel on the circulating antigen SJ 70 in murine schistosomiasis japonica.

Carter CE, Fu C, Colley DG.

Am J Trop Med Hyg. 1990 Apr;42(4):342-6.

PMID:
2109949
47.

Characterization of a large gene family in Schistosoma japonicum that encodes an immunogenic miracidial antigen.

Scallon BJ, Bogitsh BJ, Carter CE.

Mol Biochem Parasitol. 1989 Mar 1;33(2):105-12.

PMID:
2657419
48.

Priming with nondepolarizing relaxants for rapid tracheal intubation: a double-blind evaluation.

Baumgarten RK, Carter CE, Reynolds WJ, Brown JL, DeVera HV.

Can J Anaesth. 1988 Jan;35(1):5-11.

PMID:
2894903
49.

Short interval intradermal skin testing in farmed red deer (Cervus elaphus) inoculated with Mycobacterium bovis.

Corrin KC, Carter CE, Kissling RC, de Lisle GW.

N Z Vet J. 1987 Dec;35(12):204-7.

PMID:
16031352
50.

Cloning of a Schistosoma japonicum gene encoding a major immunogen recognized by hyperinfected rabbits.

Scallon BJ, Bogitsh BJ, Carter CE.

Mol Biochem Parasitol. 1987 Jul;24(3):237-45.

PMID:
3041213

Supplemental Content

Loading ...
Support Center